Publication | Open Access

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial

Breast OncologyMedicinePharmacologyPathologyBreast CancerCancer TreatmentOncologyRadiation OncologyMolecular Oncology